API
API
MN Pharmaceuticals

Macrolide Group and Pilot Plant

Macrolide group production plant became operative in 2001, and has been manufacturing macrolide group antibiotic active ingredients since then. The production plant consists of four floors spread over an area of 3000 m2. In addition to the above mentioned activities, we carry out productions on pilot scale.

  Annual Capacity
Clarithromycin powder 34.000 Kg
Clarithromycin granule 39.000 Kg

Pilot Scale Productions



• Zoledronic acid

• Disodium pamidronate

• Granisetron


(Items covered by valid patents in any country are not offered or supplied to those countries. The patent position in the concerned country should be verified by the customer).